foxo4-dri senolytic peptide human trial 2024 2025 Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis Full article: Targeting Cellular Senescence
Full article: Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging CHK2 USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis PNAS Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases[v1]
Pay in 4 interest-free payments of $5.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



